HCPCS Level II code C1874 designates a coated or covered stent supplied with its delivery system for endovascular implantation. This device-level code is used to identify the stent and its delivery mechanism on facility and professional claims when the implant is provided as part of an interventional vascular procedure. Nationally, device codes such as C1874 matter because they affect device reimbursement, device cost accounting, and coding consistency across hospitals, ambulatory surgery centers, and catheterization laboratories.

Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for use — endovascular implant/device placement in outpatient or procedural settings — and a concise discussion of payer coverage patterns and coding considerations. The publication summarizes typical billing scenarios, common modifiers in payer formularies, and where to locate reimbursement and coverage policy language.

This report provides benchmarks for facility coding practice, highlights documentation elements tied to device reporting, and outlines where to look for policy updates from major commercial payers and Medicare. Data not available in the input is noted where applicable.